ConductScience.org, home

Paper23913792

A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis.

Eifert C and 6 others. Genes Chromosomes Cancer, 2013. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis. Papers, record 23913792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23913792

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis.
PubMed
Journal
Genes Chromosomes Cancer
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
1.47
iCite
Revised in PubMed
2021-10-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Eifert CCheryl
2Wang XXianhui
3Kokabee LLeila
4Kourtidis AAntonis
5Jain RRitu
6Gerdes MJMichael J
7Conklin DSDouglas S

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApoptosisMajor topic
Breast NeoplasmsMajor topic
Protein-Tyrosine KinasesMajor topic
Agammaglobulinaemia Tyrosine Kinase
Base Sequence
Breast
Cell Line
Cell Line, Tumor
Cell Proliferation
Female
Humans
Isoenzymes
Molecular Sequence Data
RNA Interference

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA136658NCI NIH HHSUnited StatesR01CA136658PubMed and NIH
R01CA136658NCI NIH HHSUnited StatesR01CA136658PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118982164Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family.J Clin Invest2008https://conductscience.org/library/papers/18982164PubMed
214570950Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.JAMA2003https://conductscience.org/library/papers/14570950PubMed
310344731Methylation of CpGs as a determinant of transcriptional activation at alternative promoters for transforming growth factor-beta3.Cancer Res1999https://conductscience.org/library/papers/10344731PubMed
421647634Monoclonal antibody to six transmembrane epithelial antigen of prostate-4 influences insulin sensitivity by attenuating phosphorylation of P13K (P85) and Akt: possible mitochondrial mechanism.J Bioenerg Biomembr2011https://conductscience.org/library/papers/21647634PubMed
518832579
Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Am J Pathol2008https://conductscience.org/library/papers/18832579PubMed
617096862HER2 therapy: molecular mechanisms of trastuzumab resistance.Breast Cancer Res2006https://conductscience.org/library/papers/17096862PubMed
721999571Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis.BMC Genomics2011https://conductscience.org/library/papers/21999571PubMed
815180538Therapeutic potential of inhibiting Bruton's tyrosine kinase, (BTK).Curr Pharm Des2004https://conductscience.org/library/papers/15180538PubMed
911146556The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.Oncogene2000https://conductscience.org/library/papers/11146556PubMed
1012445832Phosphorylation of Bruton's tyrosine kinase by c-Abl.Biochem Biophys Res Commun2002https://conductscience.org/library/papers/12445832PubMed
1116947082The role of the epidermal growth factor receptor in breast cancer.J Mammary Gland Biol Neoplasia2006https://conductscience.org/library/papers/16947082PubMed
127705943Expression of FGF and FGF receptor genes in human breast cancer.Int J Cancer1995https://conductscience.org/library/papers/7705943PubMed
1316740702Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells.Cancer Res2006https://conductscience.org/library/papers/16740702PubMed
1411875034Computational detection and location of transcription start sites in mammalian genomic DNA.Genome Res2002https://conductscience.org/library/papers/11875034PubMed
1516166198Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression.FASEB J2005https://conductscience.org/library/papers/16166198PubMed
1619290921Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain.Immunol Rev2009https://conductscience.org/library/papers/19290921PubMed
1716200065Second-generation shRNA libraries covering the mouse and human genomes.Nat Genet2005https://conductscience.org/library/papers/16200065PubMed
1815337524Protein tyrosine kinase Syk modulates EGFR signalling in human mammary epithelial cells.Cell Signal2004https://conductscience.org/library/papers/15337524PubMed
1920096351Kinases as targets in the treatment of solid tumors.Cell Signal2010https://conductscience.org/library/papers/20096351PubMed
2017249494RNAi applications in target validation.Ernst Schering Res Found Workshop2007https://conductscience.org/library/papers/17249494PubMed

See all 54 referencesDownload CSV of references

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
42902395Profiling protein post-translational modifications in plasma-derived extracellular vesicles as fingerprints for breast cancer subtypes.Genome Biol2026https://conductscience.org/library/papers/42902395PubMed
42827714Bruton's Tyrosine Kinase Inhibitors: Mechanisms, Efficacy, Toxicities and Applications for the Treatment of Human Diseases.MedComm (2020)2026https://conductscience.org/library/papers/42827714PubMed
42071062Mutational profile of atypical fibroxanthoma and pleomorphic dermal sarcoma further expands the spectrum of genomic alterations in rare cutaneous neoplasms.Sci Rep2026https://conductscience.org/library/papers/42071062PubMed
41822319Expression of Bruton's Tyrosine Kinase Reflects Immune Cells Infiltration and Cell Proliferation in Breast Cancer.World J Oncol2026https://conductscience.org/library/papers/41822319PubMed
40445239Inhibition of head and neck squamous cell carcinoma by Bruton's tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells.Cancer Immunol Immunother2025https://conductscience.org/library/papers/40445239PubMed
39925800Case report: A panorama gene profile of ovarian cancer metastasized to axillary lymph node.Front Immunol2025https://conductscience.org/library/papers/39925800PubMed
39220827Bioinformatics analysis of BTK expression in lung adenocarcinoma: implications for immune infiltration, prognostic biomarkers, and therapeutic targeting.3 Biotech2024https://conductscience.org/library/papers/39220827PubMed
38189455Conformational heterogeneity of the BTK PHTH domain drives multiple regulatory states.Elife2024https://conductscience.org/library/papers/38189455PubMed
37738978Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach.Cell Rep Med2023https://conductscience.org/library/papers/37738978PubMed
37685940Influence of Bruton's Tyrosine Kinase (BTK) on Epithelial-Mesenchymal Transition (EMT) Processes and Cancer Stem Cell (CSC) Enrichment in Head and Neck Squamous Cell Carcinoma (HNSCC).Int J Mol Sci2023https://conductscience.org/library/papers/37685940PubMed
37638060Overexpression of Bruton Tyrosine Kinase Inhibits the Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer Cells.Anal Cell Pathol (Amst)2023https://conductscience.org/library/papers/37638060PubMed
37070569Styrylquinazoline derivatives as ABL inhibitors selective for different DFG orientations.J Enzyme Inhib Med Chem2023https://conductscience.org/library/papers/37070569PubMed
36913160Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines.Invest New Drugs2023https://conductscience.org/library/papers/36913160PubMed
36903645Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials.Molecules2023https://conductscience.org/library/papers/36903645PubMed
36612306BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression.Cancers (Basel)2023https://conductscience.org/library/papers/36612306PubMed
36139701Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs.Cancers (Basel)2022https://conductscience.org/library/papers/36139701PubMed
35992808BTK, the new kid on the (oncology) block?Front Oncol2022https://conductscience.org/library/papers/35992808PubMed
35935048Multiwalled Carbon Nanotubes as Nanomaterial Tool in the Management of Prostate Cancer: A Possible Nanoformulation Approach.Adv Pharm Bull2022https://conductscience.org/library/papers/35935048PubMed
35873012Expression Modulation of Immune Checkpoint Molecules by Ibrutinib and Everolimus Through STAT3 in MCF-7 Breast Cancer Cells.Iran J Pharm Res2022https://conductscience.org/library/papers/35873012PubMed
35732327Palmitoylation of the Alternative Amino Terminus of the BTK-C Isoform Controls Subcellular Distribution and Signaling.Cancer Genomics Proteomics2022https://conductscience.org/library/papers/35732327PubMed

See all 49 cited byDownload CSV of cited by

Genes30

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BTK695Swiss-Prot's referenceshttps://conductscience.org/library/genes/695NCBI Gene
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
ABL227PubTator's text mininghttps://conductscience.org/library/genes/27NCBI Gene
AHR196PubTator's text mininghttps://conductscience.org/library/genes/196NCBI Gene
BDNF627PubTator's text mininghttps://conductscience.org/library/genes/627NCBI Gene
BMX660PubTator's text mininghttps://conductscience.org/library/genes/660NCBI Gene
CALB1793PubTator's text mininghttps://conductscience.org/library/genes/793NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CYP19A11588PubTator's text mininghttps://conductscience.org/library/genes/1588NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EPHA12041PubTator's text mininghttps://conductscience.org/library/genes/2041NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
FGFR22263PubTator's text mininghttps://conductscience.org/library/genes/2263NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
GLB12720PubTator's text mininghttps://conductscience.org/library/genes/2720NCBI Gene
HOXA73204PubTator's text mininghttps://conductscience.org/library/genes/3204NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
LEF151176PubTator's text mininghttps://conductscience.org/library/genes/51176NCBI Gene

See all 30 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23913792

GET https://conductscience.org/api/papers/v1/23913792/references?page=2